228 related articles for article (PubMed ID: 18209591)
1. Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.
Selimoglu MA; Ertekin V; Doneray H; Yildirim M
J Clin Gastroenterol; 2008 Feb; 42(2):194-8. PubMed ID: 18209591
[TBL] [Abstract][Full Text] [Related]
2. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic bone disease in children with celiac disease is independent of symptoms at diagnosis.
Turner J; Pellerin G; Mager D
J Pediatr Gastroenterol Nutr; 2009 Nov; 49(5):589-93. PubMed ID: 19644400
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of Wilson's disease: results of a single center experience.
Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
[TBL] [Abstract][Full Text] [Related]
6. Wilson disease in children: analysis of 57 cases.
Manolaki N; Nikolopoulou G; Daikos GL; Panagiotakaki E; Tzetis M; Roma E; Kanavakis E; Syriopoulou VP
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):72-7. PubMed ID: 19172127
[TBL] [Abstract][Full Text] [Related]
7. Bone demineralisation in a large cohort of Wilson disease patients.
Weiss KH; Van de Moortele M; Gotthardt DN; Pfeiffenberger J; Seessle J; Ullrich E; Gielen E; Borghs H; Adriaens E; Stremmel W; Meersseman W; Boonen S; Cassiman D
J Inherit Metab Dis; 2015 Sep; 38(5):949-56. PubMed ID: 25663473
[TBL] [Abstract][Full Text] [Related]
8. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of abnormal bone density of pediatric patients prior to blood or marrow transplant.
Klopfenstein KJ; Clayton J; Rosselet R; Kerlin B; Termuhlen A; Gross T
Pediatr Blood Cancer; 2009 Oct; 53(4):675-7. PubMed ID: 19533650
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes.
Anaforoglu I; Nar-Demirer A; Bascil-Tutuncu N; Ertorer ME
J Diabetes Complications; 2009; 23(1):12-7. PubMed ID: 18413190
[TBL] [Abstract][Full Text] [Related]
11. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral content deficits of the spine and whole body in children at time of diagnosis with celiac disease.
Jatla M; Zemel BS; Bierly P; Verma R
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):175-80. PubMed ID: 19179879
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
[TBL] [Abstract][Full Text] [Related]
14. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
[TBL] [Abstract][Full Text] [Related]
15. Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma.
Bryant ML; Worthington MA; Parsons K
Ann Pharmacother; 2009 Apr; 43(4):714-20. PubMed ID: 19336653
[TBL] [Abstract][Full Text] [Related]
16. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
Schilsky M
Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301
[No Abstract] [Full Text] [Related]
17. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients.
Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ
Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
19. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of osteoporosis in liver cirrhosis.
Giouleme OI; Vyzantiadis TA; Nikolaidis NL; Vasiliadis TG; Papageorgiou AA; Eugenidis NP; Harsoulis FI
Hepatogastroenterology; 2006; 53(72):938-43. PubMed ID: 17153457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
